<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36747136</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>06</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study.</ArticleTitle><Pagination><StartPage>75</StartPage><MedlinePgn>75</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">75</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-023-08010-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Previous studies have shown that non-critically ill COVID-19 patients co-infected with other respiratory viruses have poor clinical outcomes. However, limited studies focused on this co-infections in critically ill patients. This study aims to evaluate the clinical outcomes of critically ill patients infected with COVID-19 and co-infected by other respiratory viruses.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A multicenter retrospective cohort study was conducted for all adult patients with COVID-19 who were hospitalized in the ICUs between March, 2020 and July, 2021. Eligible patients were sub-categorized into two groups based on simultaneous co-infection with other respiratory viruses throughout their ICU stay. Influenza A or B, Human Adenovirus (AdV), Human Coronavirus (i.e., 229E, HKU1, NL63, or OC43), Human Metapneumovirus, Human Rhinovirus/Enterovirus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), Parainfluenza virus, and Respiratory Syncytial Virus (RSV) were among the respiratory viral infections screened. Patients were followed until discharge from the hospital or in-hospital death.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 836 patients were included in the final analysis. Eleven patients (1.3%) were infected concomitantly with other respiratory viruses. Rhinovirus/Enterovirus (38.5%) was the most commonly reported co-infection. No difference was observed between the two groups regarding the 30-day mortality (HR 0.39, 95% CI 0.13, 1.20; p&#x2009;=&#x2009;0.10). The in-hospital mortality was significantly lower among co-infected patients with other respiratory viruses compared with patients who were infected with COVID-19 alone (HR 0.32 95% CI 0.10, 0.97; p&#x2009;=&#x2009;0.04). Patients concomitantly infected with other respiratory viruses had longer median mechanical ventilation (MV) duration and hospital length of stay (LOS).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Critically ill patients with COVID-19 who were concomitantly infected with other respiratory viruses had comparable 30-day mortality to those not concomitantly infected. Further proactive testing and care may be required in the case of co-infection with respiratory viruses and COVID-19. The results of our study need to be confirmed by larger studies.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Al Sulaiman</LastName><ForeName>Khalid</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Pharmaceutical Care Department, King Abdulaziz Medical City (KAMC)-Ministry of National Guard Health Affairs (MNGHA), Riyadh, Saudi Arabia. alsulaimankh@hotmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, PO Box 22490, Riyadh, 11426, Saudi Arabia. alsulaimankh@hotmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King Abdullah International Medical Research Center, Riyadh, Saudi Arabia. alsulaimankh@hotmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Saudi Critical Care Pharmacy Research (SCAPE) Platform, Riyadh, Saudi Arabia. alsulaimankh@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aljuhani</LastName><ForeName>Ohoud</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badreldin</LastName><ForeName>Hisham A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Pharmaceutical Care Department, King Abdulaziz Medical City (KAMC)-Ministry of National Guard Health Affairs (MNGHA), Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, PO Box 22490, Riyadh, 11426, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korayem</LastName><ForeName>Ghazwa B</ForeName><Initials>GB</Initials><AffiliationInfo><Affiliation>Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O.Box 84428, Riyadh, 11671, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alenazi</LastName><ForeName>Abeer A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Pharmaceutical Care Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alharbi</LastName><ForeName>Ahlam H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Pharmaceutical Care Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alghamdi</LastName><ForeName>Albandari</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O.Box 84428, Riyadh, 11671, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alhubaishi</LastName><ForeName>Alaa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O.Box 84428, Riyadh, 11671, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altebainawi</LastName><ForeName>Ali F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Pharmaceutical Care Services, King Khalid Hospital, Hail Health Cluster, Hail, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosaeed</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Infectious Disease Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alotaibi</LastName><ForeName>Rand</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O.Box 84428, Riyadh, 11671, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alawad</LastName><ForeName>Ahad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O.Box 84428, Riyadh, 11671, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alnajjar</LastName><ForeName>Nirvana</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O.Box 84428, Riyadh, 11671, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bin Saleh</LastName><ForeName>Khalid</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Pharmaceutical Care Department, King Abdulaziz Medical City (KAMC)-Ministry of National Guard Health Affairs (MNGHA), Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, PO Box 22490, Riyadh, 11426, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sait</LastName><ForeName>Walaa A</ForeName><Initials>WA</Initials><AffiliationInfo><Affiliation>Pharmaceutical Care Department, King Abdulaziz Medical City, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alsohimi</LastName><ForeName>Samiah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pharmaceutical Care Department, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pharmaceutical Care Department, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alanizy</LastName><ForeName>Meshari M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, PO Box 22490, Riyadh, 11426, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almuqbil</LastName><ForeName>Sarah A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Qassim University, Qassim, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Sulaihim</LastName><ForeName>Ibrahim</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Central Security Hospital, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vishwakarma</LastName><ForeName>Ramesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Norwich Medical School, University of East Anglia, Norwich, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alalawi</LastName><ForeName>Mai</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences, Fakeeh College for Medical Sciences, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alhassan</LastName><ForeName>Fatimah</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Pharmaceutical Care Department, King Abdulaziz Medical City (KAMC)-Ministry of National Guard Health Affairs (MNGHA), Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alghnam</LastName><ForeName>Suliman</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Population Health Section, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>BMC Infect Dis. 2023 Feb 22;23(1):103. doi: 10.1186/s12879-023-08072-8</RefSource><PMID Version="1">36814218</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="Y">Coinfection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="Y">Viruses</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018113" MajorTopicYN="Y">Respiratory Syncytial Virus, Human</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID19</Keyword><Keyword MajorTopicYN="N">Coinfection</Keyword><Keyword MajorTopicYN="N">Coronavirus disease</Keyword><Keyword MajorTopicYN="N">Critically ill</Keyword><Keyword MajorTopicYN="N">MV duration</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Outcomes</Keyword><Keyword MajorTopicYN="N">Respiratory viruses</Keyword></KeywordList><CoiStatement>No author has a conflict of interest in this study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>0</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36747136</ArticleId><ArticleId IdType="pmc">PMC9901824</ArticleId><ArticleId IdType="doi">10.1186/s12879-023-08010-8</ArticleId><ArticleId IdType="pii">10.1186/s12879-023-08010-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708&#x2013;1720. doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):266&#x2013;275. doi: 10.1016/j.jinf.2020.05.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.05.046</ArticleId><ArticleId IdType="pmc">PMC7255350</ArticleId><ArticleId IdType="pubmed">32473235</ArticleId></ArticleIdList></Reference><Reference><Citation>Malekifar P, Pakzad R, Shahbahrami R, Zandi M, Jafarpour A, Rezayat SA, et al. Viral coinfection among COVID-19 patient groups: an update systematic review and meta-analysis. Biomed Res Int. 2021;2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8416381</ArticleId><ArticleId IdType="pubmed">34485513</ArticleId></ArticleIdList></Reference><Reference><Citation>Swets MC, Russell CD, Harrison EM, Docherty AB, Lone N, Girvan M, et al. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses. Lancet. 2022;399(10334):1463&#x2013;1464. doi: 10.1016/S0140-6736(22)00383-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00383-X</ArticleId><ArticleId IdType="pmc">PMC8956294</ArticleId><ArticleId IdType="pubmed">35344735</ArticleId></ArticleIdList></Reference><Reference><Citation>Alosaimi B, Naeem A, Hamed ME, Alkadi HS, Alanazi T, Al Rehily SS, et al. Influenza co-infection associated with severity and mortality in COVID-19 patients. Virol J. 2021;18(1):1&#x2013;9. doi: 10.1186/s12985-021-01594-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-021-01594-0</ArticleId><ArticleId IdType="pmc">PMC8200793</ArticleId><ArticleId IdType="pubmed">34127006</ArticleId></ArticleIdList></Reference><Reference><Citation>Musuuza JS, Watson L, Parmasad V, Putman-Buehler N, Christensen L, Safdar N. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis. PLoS ONE. 2021;16(5):e0251170. doi: 10.1371/journal.pone.0251170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0251170</ArticleId><ArticleId IdType="pmc">PMC8101968</ArticleId><ArticleId IdType="pubmed">33956882</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma S, Lai X, Chen Z, Tu S, Qin K. Clinical characteristics of critically ill patients co-infected with SARS-CoV-2 and the influenza virus in Wuhan, China. Int J Infect Dis. 2020;96:683&#x2013;687. doi: 10.1016/j.ijid.2020.05.068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.05.068</ArticleId><ArticleId IdType="pmc">PMC7250072</ArticleId><ArticleId IdType="pubmed">32470606</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreenath K, Batra P, Vinayaraj E V., Bhatia R, SaiKiran K, Singh V, et al. Coinfections with other respiratory pathogens among patients with COVID-19. Microbiol Spectr. 2021;9(1).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8552727</ArticleId><ArticleId IdType="pubmed">34287033</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoran MA, Savastru RS, Savastru DM, Tautan MN. Assessing the relationship between surface levels of PM2.5 and PM10 particulate matter impact on COVID-19 in Milan, Italy. Sci Total Environ. 2020;738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7265857</ArticleId><ArticleId IdType="pubmed">32512362</ArticleId></ArticleIdList></Reference><Reference><Citation>Lansbury L, Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS. Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database Syst Rev. 2019;2(6):010406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6387789</ArticleId><ArticleId IdType="pubmed">30798570</ArticleId></ArticleIdList></Reference><Reference><Citation>Lansbury LE, Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS. Corticosteroids as adjunctive therapy in the treatment of influenza: an updated cochrane systematic review and meta-analysis. Crit Care Med. 2020;48(2):E98&#x2013;106. doi: 10.1097/CCM.0000000000004093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004093</ArticleId><ArticleId IdType="pubmed">31939808</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva DL, Lima CM, Magalh&#xe3;es VCR, Baltazar LM, Peres NTA, Caligiorne RB, et al. Fungal and bacterial co-infections increase mortality of severely ill COVID-19 patients. J Hosp Infect. 2021;113:145&#x2013;154. doi: 10.1016/j.jhin.2021.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2021.04.001</ArticleId><ArticleId IdType="pmc">PMC8056850</ArticleId><ArticleId IdType="pubmed">33852950</ArticleId></ArticleIdList></Reference><Reference><Citation>Chekuri S, Szymczak WA, Goldstein DY, Nori P, Marrero Rolon R, Spund B, et al. SARS-CoV-2 co-infection with additional respiratory virus does not predict severe disease: a retrospective cohort study. J Antimicrob Chemother. 2021;76(Supplement_3):III12&#x2013;III19. doi: 10.1093/jac/dkab244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkab244</ArticleId><ArticleId IdType="pmc">PMC8460099</ArticleId><ArticleId IdType="pubmed">34555160</ArticleId></ArticleIdList></Reference><Reference><Citation>Alqahtani A, Alamer E, Mir M, Alasmari A, Alshahrani MM, Asiri M, et al. Bacterial coinfections increase mortality of severely Ill COVID-19 patients in Saudi Arabia. Int J Environ Res Public Health. 2022;19(4).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8871991</ArticleId><ArticleId IdType="pubmed">35206609</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaushal K, Kaur H, Sarma P, et al. Serum ferritin as a predictive biomarker in COVID-19. A systematic review, meta-analysis and meta-regression analysis. J Crit Care. 2022;67:172&#x2013;181. doi: 10.1016/j.jcrc.2021.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2021.09.023</ArticleId><ArticleId IdType="pmc">PMC8604557</ArticleId><ArticleId IdType="pubmed">34808527</ArticleId></ArticleIdList></Reference><Reference><Citation>Djaharuddin I, Munawwarah S, Nurulita A, Ilyas M, Tabri NA, Lihawa N. Comorbidities and mortality in COVID-19 patients. Gac Sanit. 2021;35(Suppl 2):S530&#x2013;S532. doi: 10.1016/j.gaceta.2021.10.085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gaceta.2021.10.085</ArticleId><ArticleId IdType="pmc">PMC8677356</ArticleId><ArticleId IdType="pubmed">34929892</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths EC, Pedersen AB, Fenton A, Petchey OL. The nature and consequences of co-infection in humans. J Infect. 2011;63(3):200&#x2013;206. doi: 10.1016/j.jinf.2011.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2011.06.005</ArticleId><ArticleId IdType="pmc">PMC3430964</ArticleId><ArticleId IdType="pubmed">21704071</ArticleId></ArticleIdList></Reference><Reference><Citation>Echenique IA, Chan PA, Chapin KC, Andrea SB, Fava JL, Mermel LA. Clinical characteristics and outcomes in hospitalized patients with respiratory viral co-infection during the 2009 H1N1 influenza pandemic. PLoS ONE. 2013;8(4):e60845. doi: 10.1371/journal.pone.0060845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0060845</ArticleId><ArticleId IdType="pmc">PMC3622008</ArticleId><ArticleId IdType="pubmed">23585856</ArticleId></ArticleIdList></Reference><Reference><Citation>Goka EA, Vallely PJ, Mutton KJ, Klapper PE. Single, dual and multiple respiratory virus infections and risk of hospitalization and mortality. Epidemiol Infect. 2015;143(1):37&#x2013;47. doi: 10.1017/S0950268814000302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268814000302</ArticleId><ArticleId IdType="pmc">PMC9206808</ArticleId><ArticleId IdType="pubmed">24568719</ArticleId></ArticleIdList></Reference><Reference><Citation>John KJ, Nayar J, Mishra AK, Selvaraj V, Khan MS, Lal A. In-hospital clinical complications of COVID-19: a brief overview. Future Virol. 2021;16(11):717&#x2013;723. doi: 10.2217/fvl-2021-0200.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fvl-2021-0200</ArticleId><ArticleId IdType="pmc">PMC8577718</ArticleId><ArticleId IdType="pubmed">34777553</ArticleId></ArticleIdList></Reference><Reference><Citation>Farias LdPGd, Strabelli DG, Fonseca EKUN, Loureiro BMC, Nomura CH, Sawamura MVY. Thoracic tomographic manifestations in symptomatic respiratory patients with COVID-19. Radiol Bras. 2020;53(4):255. doi: 10.1590/0100-3984.2020.0030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0100-3984.2020.0030</ArticleId><ArticleId IdType="pmc">PMC7458567</ArticleId><ArticleId IdType="pubmed">32904780</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadashi M, Khaleghnejad S, Abedi Elkhichi P, Goudarzi M, Goudarzi H, Taghavi A, et al. COVID-19 and influenza co-infection: a systematic review and meta-analysis. Front Med. 2021;25(8):971.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8267808</ArticleId><ArticleId IdType="pubmed">34249971</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Sulaiman K, Korayem GB, Altebainawi AF, Al Harbi S, Alissa A, Alharthi A, et al. Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study. Crit Care. 2022;26(1):304. doi: 10.1186/s13054-022-04158-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-022-04158-y</ArticleId><ArticleId IdType="pmc">PMC9527729</ArticleId><ArticleId IdType="pubmed">36192801</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>